<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://emreview.ru/lib/pkp/xml/oai2.xsl" ?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/
		http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
	<responseDate>2026-08-15T14:47:15Z</responseDate>
	<request identifier="oai:emreview.ru:article/69" metadataPrefix="jats" verb="GetRecord">https://emreview.ru/index.php/emr/oai</request>
	<GetRecord>
		<record>
			<header>
				<identifier>oai:emreview.ru:article/69</identifier>
				<datestamp>2021-06-14T08:29:20Z</datestamp>
				<setSpec>emr:ART</setSpec>
				<setSpec>driver</setSpec>
			</header>
			<metadata>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="" dtd-version="1.4" xsi:noNamespaceSchemaLocation="https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1.xsd" xml:lang="ru">
			<front>
			<journal-meta>
				<journal-id journal-id-type="publisher">emr</journal-id><journal-id journal-id-type="ojs">emr</journal-id>
				<journal-title-group>
			<journal-title xml:lang="ru">Управление образованием: теория и практика</journal-title><trans-title-group xml:lang="en"><trans-title>Education Management Review</trans-title></trans-title-group>
</journal-title-group>			<issn pub-type="epub">2311-2174</issn>			<publisher><publisher-name>Индивидуальный предприниматель Подколзин М.М.</publisher-name></publisher>
			<self-uri xlink:href="https://emreview.ru/index.php/emr"/>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">69</article-id>
			<article-id pub-id-type="doi">10.25726/k6984-7942-2039-d</article-id>
			<article-categories><subj-group subj-group-type="heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories>
			<title-group><article-title xml:lang="ru">Педагогические условия научения будущих работников медицинской отрасли для диагностики и лечения множественной миеломы</article-title><trans-title-group xml:lang="en"><trans-title>Pedagogical conditions for teaching future employees of the medical industry for the diagnosis and treatment of multiple myeloma</trans-title></trans-title-group></title-group>
			<contrib-group content-type="author">
				<contrib contrib-type="author">
					<name-alternatives>
						<string-name specific-use="display" xml:lang="ru">Доина Яковлевна Ранга</string-name>
						<name name-style="western" specific-use="primary" xml:lang="ru">
							<surname>Ранга</surname>
							<given-names>Доина</given-names>
						</name>
						<name name-style="western" xml:lang="en">
							<surname>Ranga</surname>
							<given-names>Doina</given-names>
						</name>
					</name-alternatives>
					<xref ref-type="aff" rid="aff-1"/>
					<email>domnica2604@gmail.com</email>
					<uri>https://orcid.org/0000-0001-6695-1528</uri>
					<bio xml:lang="en"><p>student of the Department of Internal Medicine</p></bio>
					<bio xml:lang="ru"><p>студент департамента внутренней медицины</p></bio>
				</contrib>
				<contrib contrib-type="author">
					<name-alternatives>
						<string-name specific-use="display" xml:lang="ru">Василе Георгиевич Мустяцэ</string-name>
						<name name-style="western" specific-use="primary" xml:lang="ru">
							<surname>Мустяцэ</surname>
							<given-names>Василе</given-names>
						</name>
						<name name-style="western" xml:lang="en">
							<surname>Mustyatse</surname>
							<given-names>Vasile</given-names>
						</name>
					</name-alternatives>
					<xref ref-type="aff" rid="aff-1"/>
					<email>vasile.musteata@usmf.md</email>
					<uri>https://orcid.org/0000-0002-9231-5223</uri>
					<bio xml:lang="en"><p>MD, Associate Professor, Associate Professor of the Department of Internal Medicine,</p>
<p>Hematologist of the highest category of the Oncological Institute</p></bio>
					<bio xml:lang="ru"><p>доктор медицинских наук, доцент, доцент департамента внутренней медицины</p>
<p>врач-гематолог высшей категории Онкологического Института</p></bio>
				</contrib>
			</contrib-group>
			<aff-alternatives id="aff-1">
				<aff xml:lang="ru"><institution content-type="orgname">Государственный университет медицины и фармакологии имени Николая Тестемицану</institution></aff>
				<aff xml:lang="en"><institution content-type="orgname">Nicolae Testemitanu State University of Medicine and Pharmacology</institution></aff>
			</aff-alternatives>
			<pub-date date-type="collection"><year>2021</year></pub-date><pub-date date-type="pub" publication-format="epub"><day>11</day><month>05</month><year>2021</year></pub-date>
			<volume seq="6">11</volume>
			<issue>3</issue>
				<issue-id>43</issue-id><issue-title xml:lang="ru">Управление образованием, №3 (43), 2021</issue-title><issue-title xml:lang="en">Education management review, №3 (43), 2021</issue-title><fpage>50</fpage>
				<lpage>58</lpage>
			<permissions>
				<copyright-statement xml:lang="ru">© 2021 Управление образованием: теория и практика</copyright-statement>
				<copyright-statement xml:lang="en">© 2021 Education Management Review</copyright-statement>
				<copyright-year>2021</copyright-year>
				<copyright-holder xml:lang="ru">Управление образованием: теория и практика</copyright-holder>
				<copyright-holder xml:lang="en">Education Management Review</copyright-holder>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0" xml:lang="ru">
					<license-p>Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.</license-p>
				</license>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0" xml:lang="en">
					<license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.</license-p>
				</license>
				<license license-type="open-access" specific-use="metadata" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/" xml:lang="ru">
					<license-p>Метаданные настоящей записи распространяются на условиях Creative Commons CC0 1.0 (передача в общественное достояние).</license-p>
				</license>
				<license license-type="open-access" specific-use="metadata" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/" xml:lang="en">
					<license-p>The metadata of this record are distributed under the Creative Commons CC0 1.0 Universal Public Domain Dedication.</license-p>
				</license>
			</permissions>
			
			
			<self-uri xlink:href="https://emreview.ru/index.php/emr/article/view/69/65" content-type="application/pdf"/><self-uri xlink:href="https://emreview.ru/index.php/emr/article/view/69"/>
			
			
			
			<abstract xml:lang="ru"><p>Теоретическая подготовка будущих врачей в России была и остается на удовлетворительном уровне, однако значительно ухудшилась практическая подготовка врачей общей практики и других специальностей, на что влияют субъективные и объективные факторы. Хотя теоретическая подготовка студентов VI курса до сих пор сохраняется на удовлетворительном уровне, практическая подготовка врачей после окончания вуза значительно отстает. Указанное обусловлено тем, что кафедры внутренней медицины, на которых закладываются основы подготовки врача любой специальности, очень плохо оснащены диагностической, научной и недостаточно — учебной аппаратурой, которая должна использоваться в учебном процессе. Ежегодно из учреждений медицинского и фармацевтического образования Минздрава выпускается более 10 тысяч человек образовательного уровня «специалист» (магистр). В то же время, эффективной системы прогнозирования потребности в медицинских кадрах пока нет. Существующие реестры медицинских работников не отражают реальной картины, поскольку построены по советским принципам. Реформа финансирования системы здравоохранения, начатая в 2017 году, приведет к изменению количества и функциональных обязанностей медицинского персонала. Соответственно, любое долгосрочное прогнозирование потребует корректировки. Множественная миелома – парапротеинемический гемобластоз, который характеризуется злокачественной опухолевой пролиферацией плазматических клеток одного клона с гиперпродукцией моноклонального иммуноглобулина или свободных моноклональных цепей иммуноглобулинов, достаточно сложное заболевание, требующее значительных диагностических и практических усилий для соответствующего лечения. Именно поэтому, важность обучения диагностики и лечения множественной миеломы студентами медицинских вузов является актуальной задачей.</p></abstract><trans-abstract xml:lang="en"><p>The theoretical training of future doctors in Russia has been and remains at a satisfactory level, but the practical training of general practitioners and other specialties has deteriorated significantly, which is influenced by subjective and objective factors. Although the theoretical training of the sixth-year students is still at a satisfactory level, the practical training of doctors after graduation is far behind. This is due to the fact that the departments of internal medicine, which lay the foundations for the training of a doctor of any specialty, are very poorly equipped with diagnostic, scientific and insufficiently — educational equipment that should be used in the educational process. Every year, more than 10 thousand people of the "specialist" (Master's) educational level graduate from the medical and pharmaceutical education institutions of the Ministry of Health. At the same time, there is no effective system for predicting the need for medical personnel yet. The existing registers of medical workers do not reflect the real picture, because they are built on Soviet principles. The reform of the financing of the health care system, launched in 2017, will lead to a change in the number and functional responsibilities of medical personnel. Accordingly, any long-term forecasting will require adjustments. Multiple myeloma-paraproteinemic hemoblastosis, which is characterized by malignant tumor proliferation of plasma cells of a single clone with hyperproduction of monoclonal immunoglobulin or free monoclonal chains of immunoglobulins, is a fairly complex disease that requires significant diagnostic and practical efforts for appropriate treatment. That is why the importance of teaching the diagnosis and treatment of multiple myeloma to medical students is an urgent task.</p></trans-abstract><kwd-group xml:lang="ru"><title>Ключевые слова</title><kwd>Множественная миелома, миеломная болезнь, плазмоцитома, генетические изменения.</kwd></kwd-group><kwd-group xml:lang="en"><title>Keywords</title><kwd>Multiple myeloma, myeloma, plasmocytoma, genetic changes.</kwd></kwd-group><funding-group>
				<funding-statement xml:lang="ru">Исследование выполнено без внешнего финансирования.</funding-statement>
				<funding-statement xml:lang="en">The study was conducted without external funding.</funding-statement>
			</funding-group>
			<counts><page-count count="9"/></counts>
			<custom-meta-group>
				<custom-meta>
					<meta-name>production-ready-file-url</meta-name>
					<meta-value><ext-link ext-link-type="uri" xlink:href="https://emreview.ru/index.php/emr/jatsTemplate/download?submissionFileId=132&amp;fileId=132&amp;submissionId=69&amp;stageId=5"/></meta-value>
				</custom-meta>
				<custom-meta>
					<meta-name>production-ready-file-url</meta-name>
					<meta-value><ext-link ext-link-type="uri" xlink:href="https://emreview.ru/index.php/emr/jatsTemplate/download?submissionFileId=134&amp;fileId=134&amp;submissionId=69&amp;stageId=5"/></meta-value>
				</custom-meta>
				<custom-meta>
					<meta-name>metadata-license</meta-name>
					<meta-value><ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</ext-link></meta-value>
				</custom-meta>
			<custom-meta><meta-name>issue-cover</meta-name><meta-value><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://emreview.ru/public/journals/1/cover_issue_43_ru_RU.png"/></meta-value></custom-meta></custom-meta-group>
		</article-meta>
	</front>
	<body><p/></body>
	<back>
		<ref-list xml:lang="ru">
			<title>Список литературы</title>
			<ref id="R1"><mixed-citation>Bhutani, M., Foureau, D. M., Atrash, S., Voorhees, P. M., &amp; Usmani, S. Z. (2020). Extramedullary multiple myeloma. Leukemia, 34(1). https://doi.org/10.1038/s41375-019-0660-0</mixed-citation></ref>
			<ref id="R2"><mixed-citation>Campbell, J. P., Heaney, J. L. J., Pandya, S., Afzal, Z., Kaiser, M., Owen, R., … Drayson, M. T. (2017). Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study. The Lancet Haematology, 4(12), e584–e594. https://doi.org/10.1016/S2352-3026(17)30209-0</mixed-citation></ref>
			<ref id="R3"><mixed-citation>Dabbah, M., Attar-Schneider, O., Zismanov, V., Matalon, S. T., Lishner, M., &amp; Drucker, L. (2016). Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation. Journal of Leukocyte Biology, 100(4), 761–770. https://doi.org/10.1189/jlb.3A1115-510RR</mixed-citation></ref>
			<ref id="R4"><mixed-citation>Dima, D., Dower, J., Comenzo, R. L., &amp; Varga, C. (2020). Evaluating daratumumab in the treatment of multiple myeloma: Safety, efficacy and place in therapy. Cancer Management and Research, 12, 7891–7903. https://doi.org/10.2147/CMAR.S212526</mixed-citation></ref>
			<ref id="R5"><mixed-citation>Feng, M., Luo, X., Gu, C., &amp; Fei, J. (2015). Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells. Journal of Drug Targeting, 23(1), 59–66. https://doi.org/10.3109/1061186X.2014.951653</mixed-citation></ref>
			<ref id="R6"><mixed-citation>Kabir, A. L., Rahman, M. J., Begum, M., Dipta, T. F., Baqui, M. N., Aziz, A., … Habib, M. A. (2012). Response of vincristine, melphalan, cyclophosphamide and prednisolone in refractory multiple myeloma. Mymensingh Medical Journal : MMJ, 21(1), 114–119.</mixed-citation></ref>
			<ref id="R7"><mixed-citation>Kunacheewa, C., &amp; Manasanch, E. E. (2020). High-risk smoldering myeloma versus early detection of multiple myeloma: Current models, goals of therapy, and clinical implications. Best Practice and Research: Clinical Haematology, 33(1). https://doi.org/10.1016/j.beha.2020.101152</mixed-citation></ref>
			<ref id="R8"><mixed-citation>Lee, W., Chen, R. C., Swaminathan, S. K., &amp; Ho, C. L. (2019). Extramedullary multiple myeloma with central nervous system and multiorgan involvement: Case report and literature review. Journal of Radiology Case Reports, 13(12), 1–12. https://doi.org/10.3941/jrcr.v13i12.3784</mixed-citation></ref>
			<ref id="R9"><mixed-citation>Li, Q., &amp; Liu, Z.-S. (2013). Source and differentiation of multiple myeloma stem cells. Chinese Journal of Tissue Engineering Research, 17(10), 1891–1895. https://doi.org/10.3969/j.issn.2095-4344.2013.10.028</mixed-citation></ref>
			<ref id="R10"><mixed-citation>Manier, S., Kawano, Y., Bianchi, G., Roccaro, A. M., &amp; Ghobrial, I. M. (2016). Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma. Current Opinion in Hematology, 23(4), 426–433. https://doi.org/10.1097/MOH.0000000000000259</mixed-citation></ref>
			<ref id="R11"><mixed-citation>Rajkumar, S. V, &amp; Kyle, R. A. (2013). Diagnosis and treatment of multiple myeloma. Neoplastic Diseases of the Blood. https://doi.org/10.1007/978-1-4614-3764-2_33</mixed-citation></ref>
			<ref id="R12"><mixed-citation>Shpilberg, K. A., Esses, S. J., Fowkes, M. E., Chari, A., Sacher, M., &amp; Naidich, T. P. (2015). Imaging of extraosseous intracranial and intraspinal multiple myeloma, including central nervous system involvement. Clinical Imaging, 39(2), 213–219. https://doi.org/10.1016/j.clinimag.2014.11.017</mixed-citation></ref>
			<ref id="R13"><mixed-citation>Xu, L., Mohammad, K. S., Wu, H., Crean, C., Poteat, B., Cheng, Y., … Srour, E. F. (2016). Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma. Cancer Research, 76(23), 6901–6910. https://doi.org/10.1158/0008-5472.CAN-16-0517</mixed-citation></ref>
			<ref id="R14"><mixed-citation>Yang, Y., Wang, S., Li, J., Qi, S., &amp; Zhang, D. (2017). CUL4A as a marker and potential therapeutic target in multiple myeloma. Tumor Biology, 39(7), 1–7. https://doi.org/10.1177/1010428317703923</mixed-citation></ref>
			<ref id="R15"><mixed-citation>Zhang, X. Y., Rajagopalan, D., Chung, T.-H., Hooi, L., Toh, T. B., Tian, J. S., … Chow, E. K.-H. (2020). Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma. Experimental Hematology and Oncology, 9(1). https://doi.org/10.1186/s40164-020-00164-4</mixed-citation></ref>
		</ref-list>
	</back>
</article>			</metadata>
		</record>
	</GetRecord>
</OAI-PMH>
